Brief: Shanghai Junshi Biosciences Unit Entered Into License, Cooperation Agreement
26/09/2024 15:53
Sept 26 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* UNIT AND NANJING JSIAMA BIOPHARMACEUTICALS ENTERED INTO
LICENSE,
COOPERATION AGREEMENT FOR IAMA-001 NASAL SPRAY PROJECT
Further company coverage: 688180.SS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab